ready for take off

BRW published last week that Amrad was prime take over company with over $60 million in cash and a market cap of only $92 million.(nta = 51 cents)
Companies were on the look out for such cashed up biotech outfit's.
With its drug research programs now streamlined , extensive collaboration with the giant pharmaceutical Merck who are paying large US$ milestone payments on AML's executed Asthma research,a company share buy back scheme in motion, Thorney investments taking a larger slice (backed by billionaire Dick Pratt) and an appreciating share price of late it would be hard to ignore this stock at present.
Do your research and keep your eyes solidly glued on this stock chap's.


to believe o